Silicone oil removal time extension possible for high-risk patients

Article

Silicone oil removal time could be increased for up to one year to achieve a stable retinal status in patients with high-risk redetachment.

Silicone oil removal time could be increased for up to one year to achieve a stable retinal status in patients with high-risk redetachment, states a paper in Eye.

A team headed by Dr Yasin Toklu, Department of Ophthalmology, Ankara Atatürk Training and Research Hospital, Ankara, Turkey, monitored 32 cases that were thought to have a high-risk of retinal redetachment after silicone oil removal.

The silicone oil was kept as long as possible until the first signs of silicone oil emulsification were identified. The silicone oil emulsification times varied between 5 and 24 months with a mean of 13.2 ± 4.8 months.

In the majority of cases, emulsification occurred within the first year, but two cases did not experience emulsification until the month 24.

The abstract can be read by visiting this link.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.